IIPR

$IIPR

Innovative Industrial Properties

REIT specializing in sale-leaseback transactions with state-licensed cannabis operators.

Cannabis
$55.54
+0.71 (+1.29%)
Day Range$55.51 - $56.15
Prev Close$54.83

IIPR key facts as of November 7, 2026

Latest AI research report
IIPR: High Yield, AFFO Recovery, Dividend Risk (as of November 7, 2026)
StockAlpha report sentiment
Neutral (as of November 7, 2026)
Analyst consensus
Hold (0 Strong Buy, 2 Buy, 4 Hold, 0 Sell, 1 Strong Sell) (as of November 1, 2026)
Analyst price target
$56.25 mean (range $56.25 to $56.25) (as of November 9, 2026)
Sector
Cannabis
Analyst Rating
Hold
2 Buy / 4 Hold / 1 Sell
Price Target
$56.25
1.3% upside
Subscribers
0
Tracking this ticker
Latest Report

Analysis from Nov 7, 2026

NEUTRAL

IIPR: High Yield, AFFO Recovery, Dividend Risk

Innovative Industrial Properties (IIPR) reported a Q3 2026 EPS beat and AFFO improvements, but dividend coverage and underlying leasing trends leave upside limited. Analysts are largely neutral with price targets clustered around $56.

Nov 7, 2026

IIPR FAQ

What is StockAlpha's latest view on IIPR?

StockAlpha's latest AI research report on Innovative Industrial Properties (IIPR), "IIPR: High Yield, AFFO Recovery, Dividend Risk", was published on November 7, 2026 and rates the overall sentiment as neutral. Innovative Industrial Properties (IIPR) reported a Q3 2026 EPS beat and AFFO improvements, but dividend coverage and underlying leasing trends leave upside limited. Analysts are largely neutral with price targets clustered around $56.

When was the IIPR research last updated?

The most recent IIPR report was published on November 7, 2026.

What do analysts expect for IIPR?

As of November 1, 2026, the analyst consensus on IIPR is Hold (0 Strong Buy, 2 Buy, 4 Hold, 0 Sell, 1 Strong Sell). As of November 9, 2026, the analyst price target is $56.25 mean (range $56.25 to $56.25).

Is this IIPR research investment advice?

No. StockAlpha.ai research is AI-generated analysis for informational purposes only and is not investment advice. Analyst figures are third-party data. Do your own research before making investment decisions.

Keep exploring